Ignite Creation Date:
2025-12-26 @ 11:12 PM
Ignite Modification Date:
2026-03-11 @ 12:29 AM
Study NCT ID:
NCT01633112
Status:
TERMINATED
Last Update Posted:
2019-05-28
First Post:
2012-06-29
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
MS Study Evaluating Safety and Efficacy of Two Doses of Fingolimod Versus Copaxone
Sponsor:
Novartis Pharmaceuticals
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Relapsing-remitting Multiple Sclerosis (RRMS) | View |
Keywords: